Non small cell lung cancers trang 1 tải miễn phí từ TAILIEUCHUNG

"Non small cell lung cancers" trang 1 - tải miễn phí từ Tailieuchung

Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelialmesenchymal transition signature and longer survival in squamous cell lung carcinoma

Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelialmesenchymal transition signature and longer survival in squamous cell lung carcinoma

10 36 1

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers

9 28 1

High frequency of epidermal growth factor receptor mutations in non - small cell lung cancers in Vietnam

High frequency of epidermal growth factor receptor mutations in non - small cell lung cancers in Vietnam

12 58 0

Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer

Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer

12 29 1

Novel biomarkers that assist in accurate discrimination of squamous cell carcinoma from adenocarcinoma of the lung

Novel biomarkers that assist in accurate discrimination of squamous cell carcinoma from adenocarcinoma of the lung

10 52 1

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation

5 28 1

MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1

MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1

11 26 1

Comparative analysis of overall survival in non-small cell lung cancer patients with and without different organ metastases

Comparative analysis of overall survival in non-small cell lung cancer patients with and without different organ metastases

6 1 1

LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR433-3p to upregulate WTAP

LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR433-3p to upregulate WTAP

11 29 1

Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinumbased chemotherapy

Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinumbased chemotherapy

8 26 1

MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18

MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18

8 18 1

A retrospective study of alectinib versus ceritinib in patients with advanced non– small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed

A retrospective study of alectinib versus ceritinib in patients with advanced non– small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed

8 44 1

A composite biomarker of neutrophillymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

A composite biomarker of neutrophillymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

11 10 1

Non-small cell lung cancer with EML4-ALK translocation in Chinese male never-smokers is characterized with early-onset

Non-small cell lung cancer with EML4-ALK translocation in Chinese male never-smokers is characterized with early-onset

10 28 1

Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility

Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility

16 52 1

Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: A critical review

Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: A critical review

9 47 1

NDRG1 downregulates ATF3 and inhibits cisplatininduced cytotoxicity in lung cancer A549 cells

NDRG1 downregulates ATF3 and inhibits cisplatininduced cytotoxicity in lung cancer A549 cells

6 58 0

Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis

Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis

13 9 1

Immunotherapy for non-small cell lung cancers: Biomarkers for predicting responses and strategies to overcome resistance

Immunotherapy for non-small cell lung cancers: Biomarkers for predicting responses and strategies to overcome resistance

10 40 1

The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells

The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells

13 28 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.